Table 1. List of the 12 probe sets associated with prognostic value in DLBCL patients.
Hazard ratios (HR) are indicated for each gene used to design GEP-based risk score (GERS) in DLBCL patients. Probe sets are sorted by increasing HR.
| Probe set | Gene symbol | Gene name | Hazard Ratio (HR) |
|---|---|---|---|
| 1569773_at | ATP8A1 | ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 | 0.2353597 |
| 229435_at | GLIS3 | GLIS family zinc finger 3 | 0.3969455 |
| 1554413_s_at | RUNDC2B | RUN domain containing 2B | 0.4002619 |
| 230121_at | C1orf133 | Chromosome 1 open reading frame 133 | 0.4067606 |
| 240777_at | SYNE2 | Spectrin repeat containing, nuclear envelope 2 | 0.4144356 |
| 213906_at | MYBL1 | v-myb myeloblastosis viral oncogene homolog (avian)-like 1 | 0.4203686 |
| 235743_at | --- | --- | 0.4269757 |
| 234284_at | GNG8 | Guanine nucleotide binding protein (G protein), gamma 8 | 0.4384588 |
| 206500_s_at | C14orf106 | Chromosome 14 open reading frame 106 | 0.4767180 |
| 218792_s_at | BSPRY | B-box and SPRY domain containing | 2.0686670 |
| 221275_s_at | --- | --- | 2.1554317 |
| 205774_at | F12 | Coagulation factor XII (Hageman factor) | 2.6380675 |